Canada· CA-DIN-02246805
THYMOGLOBULIN
A antithymocyte immunoglobulin (rabbit) product containing anti-thymocyte globulin (rabbit), registered in Canada by SANOFI-AVENTIS CANADA INC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Antithymocyte immunoglobulin (rabbit) is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AA04 (antithymocyte immunoglobulin (rabbit)), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Antithymocyte immunoglobulin (rabbit) · ATC L04AA04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ANTI-THYMOCYTE GLOBULIN (RABBIT)
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Country
- Canada (CA)
- ATC code
- L04AA04
- ATC class
- Antithymocyte immunoglobulin (rabbit)
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Antithymocyte immunoglobulin (rabbit) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGRAFALONNeovii Biotech GmbH, Gräfelfing
- SwitzerlandGrafalon
- United KingdomGrafalon 100mg/5ml concentrate for solution for infusion vialsImported (Germany)
- SpainGRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONNeovii Biotech Gmbh
- United StatesThymoglobulinGenzyme Corporation
- NetherlandsGrafalon 20 mg/ml concentraat voor oplossing voor infusieNeovii Biotech GmbH
- IrelandThymoglobuline 25 mg powder for solution for infusionSanofi B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f205150-3a27-49fc-b3af-bdbc5d7cea72 GET /v1/drugs/5f205150-3a27-49fc-b3af-bdbc5d7cea72?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02246805",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L04AA04",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "71005",
"strengths": [
"25 MG"
],
"ahfs_class": null,
"substances": [
"ANTI-THYMOCYTE GLOBULIN (RABBIT)"
],
"product_categorization": null
}See everything about antithymocyte immunoglobulin (rabbit).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.